Mycotoxins are secondary metabolites produced by certain filamentous fungi (e.g., Aspergillus, Penicillium, and Fusarium) that pose a toxicological risk even at trace concentrations. While rare in synthetic peptides and chemically synthesized small molecules, Pinnacle Compounds maintains a precautionary testing standard for mycotoxins in any raw material or excipient of botanical origin or environmental exposure risk. Using high-sensitivity liquid chromatography tandem mass spectrometry (LC-MS/MS), we screen for a panel of regulated mycotoxins including aflatoxins (B1, B2, G1, G2), ochratoxin A, fumonisins, and zearalenone. All detected levels must fall below regulatory action limits defined by the U.S. Pharmacopeia (USP), the European Pharmacopoeia (Ph. Eur.), and the Codex Alimentarius. This ensures the exclusion of genotoxic, hepatotoxic, or immunosuppressive agents from research products, protecting both biological models and laboratory personnel.